Abstract：Objective To investigate whether lncRNA LINC00909 affected the radiosensitivity of colorectal cancer cells by targeting miR-548-3p. Methods The expression levels of LINC00909 and miR-584-3p in colorectal cancer and adjacent tissues were detected by qRT-PCR. The colorectal cancer cells SW480 and SW620 were cultured in vitro, and transfected with si-NC, si-LINC00909, miR-NC, miR-584-3p mimics, si-LINC00909, and anti-miR-NC and si-LINC00909, and anti-miR-584-3p, respectively. The cells were irradiated with a dose of 4 Gy. The cell survival fraction and sensitization enhancement ratio (SER) were detected by clone formation assay. Cell proliferation was detected by MTT assay. Cell migration and invasion were assessed by Trans well chamber assay. The targeting relationship between LINC00909 and miR-584-3p was confirmed by dual luciferase reporter assay. The effect of interfering with the expression of LINC00909 or inhibiting the expression of miR-584-3p on the weight of the xenograft tumor after irradiation was evaluated by subcutaneous xenograft experiment in nude mice. Results The expression level of LINC00909 in colorectal cancer tissues was significantly up-regulated (P<0.05), whereas the expression level of miR-584-3p was significantly down-regulated (P<0.05). After interfering with the expression of LINC00909 or miR-584-3p overexpression, the cell survival fraction score was significantly reduced (P<0.05), the SERs were 2.017 and 1.762, and cell proliferation, migration and invasion were suppressed (all P<0.05). Dual luciferase reporter assay confirmed that LINC00909 could target and bind to miR-584-3p. After interfering with the expression of LINC00909, the weight of the transplanted tumor was significantly reduced (P<0.05), whereas the weight of the transplanted tumor was significantly increased after co-transfection with anti-miR-584-3p (P<0.05). Conclusion Interfering with the expression of LINC00909 can inhibit the proliferation, migration and invasion ability of colorectal cancer cells by up-regulating the expression of miR-548-3p, thereby enhancing the cell radiosensitivity.
Hou Ge,Xiao Chenhu,Chen Xiaojuan et al. Radiosensitivity of lncrna linc00909 targeting mir-548-3p on colorectal cancer cells[J]. Chinese Journal of Radiation Oncology, 2020, 29(12): 1110-1117.
[1] Kang Z, Jifu E, Guo K, et al. Knockdown of long non-coding RNA TINCR decreases radioresistance in colorectal cancer cells[J]. Pathol Res Pract, 2019, 215(11):152622-152632. DOI:10.1016/j.prp.2019.152622. [2] 孙献涛, 练延帮, 白杨, 等. LncRNA CRNDE靶向miR-384影响结直肠癌细胞放射敏感性的研究[J]. 中华放射医学与防护杂志, 2019, 39(12):893-898. DOI:10.3760/cma.j.issn.0254-5098.2019.12.003. Sun XT, Lian YB, Bai Y, et al. Effect of lncrna crnde targeting mir-384 on radiosensitivity of colorectal cancer cells[J]. Chin J Radiol Med Protect, 2019, 39(12):893-898. DOI:10.3760/cma.j.issn.0254-5098.2019.12.003. [3] 李孝敏, 赵浩亮, 马鹏, 等. lncRNA GAS5通过下调miR-223的表达提高结肠癌细胞的放射敏感性[J]. 中华放射医学与防护杂志, 2018, 38(10):734-740. DOI:10.3760/cma.j.issn.0254-5098.2018.10.003. Li XM, Zhao HL, Ma P, et al. LncRNA GAS5 enhances radiosensitivity of colon cancer cells by down regulating the expression of miR-223[J]. Chin J Radiol Med Protect, 2018, 38(10):734-740. DOI:10.3760/cma.j.issn.0254-5098.2018.10.003. [4] 陈小燕, 吴陈宾, 田昕, 等. LncRNA ANRIL靶向miR-195对HCT116细胞及裸鼠移植瘤放射增敏实验研究[J]. 中华放射肿瘤学杂志, 2019, 28(11):858-861. DOI:10.3760/cma.j.issn.1004-4221.2019.11.013. Chen XY, Wu CB, Tian X, et al. Experimental study on radiosensitization of lncrna anril targeted miR-195 on HCT116 cells and xenografts in nude mice[J]. Chin J Radiat Oncol, 2019, 28(11):858-861. DOI:10.3760/cma.j.issn.1004-4221.2019.11.013. [5] Ma L, Wang YY, Jiang P. LncRNA LINC00909 promotes cell proliferation and metastasis in pediatric acute myeloid leukemia via miR-625-mediated modulation of Wnt/b-catenin signaling[J]. Biochem Biophys Res Commun, 2020, 527(3):654-661. DOI:10.1016/j.bbrc.2020.05.001. [6] Zheng L, Chen Y, Ye L, et al. miRNA-584-3p inhibits gastric cancer progression by repressing Yin Yang 1-facilitated MMP-14 expression[J]. Sci Rep, 2017, 7(1):8967-8977. DOI:10.1038/s41598-017-09271-5. [7] Yang X, Liu W, Xu X, et al. Downregulation of long non?Bcoding RNA UCA1 enhances the radiosensitivity and inhibits migration via suppression of epithelial?Bmesenchymal transition in colorectal cancer cells[J]. Oncol Rep, 2018, 40(3):1554-1564. DOI:10.3892/or.2018.6573. [8] Liu Y, Chen X, Chen X, et al. Long non-coding RNA HOTAIR knockdown enhances radiosensitivity through regulating microRNA-93/ATG12 axis in colorectal cancer[J]. Cell Death Dis, 2020, 11(3):175-185. DOI:10.1038/s41419-020-2268-8. [9] Wang AH, Fan WJ, Fu L, et al. LncRNA PCAT-1 regulated cell proliferation, invasion, migration and apoptosis in colorectal cancer through targeting miR-149-5p[J]. Eur Rev Med Pharmacol Sci, 2019, 23(19):8310-8320. DOI:10.26355/eurrev_201910_19142. [10] Xiong W, Qin J, Cai X, et al. Overexpression LINC01082 suppresses the proliferation, migration and invasion of colon cancer[J]. Mol Cell Biochem, 2019, 462(1-2):33-40. DOI:10.1007/s11010-019-03607-7. [11] Liu Z, Wang N, Wang F, et al. Silencing of lncRNA EZR-AS1 inhibits proliferation, invasion, and migration of colorectal cancer cells through blocking transforming growth factor β signaling[J]. Biosci Rep, 2019, 39(11):1-10. DOI:10.1042/BSR20191199. [12] Liu Z, Lu C, Hu H, et al. LINC00909 promotes tumor progression in human glioma through regulation of miR-194/MUC1-C axis[J]. Biomed Pharmacother, 2019, 116(1):108965-108975. DOI:10.1016/j.biopha.2019.108965. [13] Xu W, Zhou G, Wang H, et al. Circulating lncRNA SNHG11 as a novel biomarker for early diagnosis and prognosis of colorectal cancer[J]. Int J Cancer, 2020, 146(10):2901-2912. DOI:10.1002/ijc.32747. [14] Huang H, Cai L, Li R, et al. A novel lncRNA LOC101927746 accelerates progression of colorectal cancer via inhibiting miR-584-3p and activating SSRP1[J]. Biochem Biophys Res Commun, 2019, 509(3):734-738. DOI:10.1016/j.bbrc.2018.12.174. [15] Shi Y, Qiu M, Wu Y, et al. MiR-548-3p functions as an anti-oncogenic regulator in breast cancer[J]. Biomed Pharmacother, 2015, 75(1):111-116. DOI:10.1016/j.biopha.2015.07.027.
2020, Vol. 29 
